ArticleJournal of clinical pharmacology2026

Suzetrigine Is Not Expected to Have Clinically Relevant DDIs with Apixaban and Rivaroxaban Based on PBPK Modeling.

Guanyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.